Articles contained in this library reflect the impact of the pandemic on patient harm in the acute care setting.
Washington, DC: United States Government Accountability Office; November 30, 2021. Publication GAO-22-105142.
The medication-use process is highly complex with many steps and risk points for error, and those errors are a key target for improving safety. This Library reflects a curated selection of PSNet content focused on medication and drug errors. Included resources explore understanding harms from preventable medication use, medication safety improvement strategies, and resources for design.
Diagnostic error has been increasingly recognized as an important and evolving patient safety issue. This Primer applies well-established principles of diagnostic error and improvement of diagnostic accuracy to the topic of COVID-19.
Gebeloff R, Thomas K, Silver-Greenberg J. New York Times. December 9, 2021.
Rockville, MD: Agency for Healthcare Research and Quality. January 12, 2:00-3:00 PM (eastern).
Deprescribing is an intervention used to reduce the risk of adverse drug events (ADEs) that can result from polypharmacy. It is the process of supervised medication discontinuation or dose reduction to reduce potentially inappropriate medication (PIM) use.
Agency for Healthcare Quality and Research. Fed Register. September 21, 2021;86:52471-52473.
Thomas K, Gebeloff R, Silver-Greenberg J. New York Times. September 11, 2021.
Rockville, MD: Agency for Healthcare Research and Quality; September 9, 2021. PA-21-267.